<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03049657</url>
  </required_header>
  <id_info>
    <org_study_id>ANGIOLITE</org_study_id>
    <nct_id>NCT03049657</nct_id>
  </id_info>
  <brief_title>Efficacy of Angiolite Stent vs a Second-generation Drug-eluting Stent Xience for Percutaneous Coronary Intervention</brief_title>
  <official_title>Randomized Clinical Trial to Compare the Efficacy of Angiolite Stent Versus a Second-generation Drug-eluting Stent Such as Xience in Patients With Indication of Percutaneous Coronary Intervention</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cardiva2 S.L.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cardiva2 S.L.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Clinical trial with an &quot;European Community marked&quot; medical device in patients with ischemic
      heart disease and clinical indication of coronary revascularization with drug-eluting stent.

      Clinical follow-up will be done according to this way: first month telephone or face-to-face
      interview and at 6 ± 1 month an Angiography follow up + OCT (optical coherence tomography)

      A randomized clinical trial to compare the efficacy of Angiolite Stent versus a
      second-generation drug-eluting stent such as Xience stent.(non-inferiority design)
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">February 2, 2016</start_date>
  <completion_date type="Anticipated">February 2018</completion_date>
  <primary_completion_date type="Actual">March 31, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy</measure>
    <time_frame>6 months</time_frame>
    <description>Measure whether the late loss (LL) at follow-up of the Angiolite stent is not different from the late loss xience (non-inferiority stent) Primary endpoint assessment will be the intra stent late loss at 6 months. Intra-stent late loss: difference between intra-stent minimum luminal diameter immediately after the procedure and the obtained at angiographic follow-up.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Security</measure>
    <time_frame>6 months</time_frame>
    <description>Compare the major adverse cardiac events rate (non fatal myocardial infarction, cardiovascular death, need of new revascularization in target lesion or stent thrombosis) between Angiolite and Xience stent during the follow-up</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Follow up</measure>
    <time_frame>1 year</time_frame>
    <description>Compare differences between Angiolite and Xience stent during the follow-up in independent components of the major adverse cardiac events rate in follow-up: non fatal myocardial infarction, cardiovascular death, need of new revascularization in target lesion and stent thrombosis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Thrombosis rate</measure>
    <time_frame>1 year</time_frame>
    <description>Discard differences in definite and probable thrombosis rate (according to Academic Research Consortium criteria) between both stents Angiolite and Xience</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">220</enrollment>
  <condition>Coronary Artery Disease</condition>
  <condition>Drug-eluting Stent</condition>
  <arm_group>
    <arm_group_label>ANGIOLITE</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Compare the efficacy of Angiolite Stent versus a second-generation drug-eluting stent such as Xience stent.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Xience</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Compare the efficacy of Angiolite Stent versus a second-generation drug-eluting stent such as Xience stent.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Angiolite</intervention_name>
    <description>Percutaneous coronary intervention</description>
    <arm_group_label>ANGIOLITE</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Xience</intervention_name>
    <description>Percutaneous coronary intervention</description>
    <arm_group_label>Xience</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with clinical or subclinical ischemic heart disease with indication of
             percutaneous revascularization.

          -  &quot;De Novo&quot; lesions ≥ 70%

          -  Reference diameters ≥ 2 mm and ≤ 4 mm Accepted participation in the registration with
             the signing of informed consent

        Exclusion Criteria:

          -  Cardiogenic shock

          -  Pregnancy

          -  Intolerance or allergy to anti platelet or anticoagulant therapy

          -  Elective surgical procedure scheduled within 6 months after inclusion in the study

          -  Expectancy of life of less than 1 year.

          -  Impossibility of doing 1 year clinical follow-up.

          -  Primary angioplasty in patients with killip class III-IV or mechanical complications.

          -  Patient with pre-procedure restenosis.

          -  Patients who will not be treated all lesions with the Angiolite stent.

          -  Total occlusions

          -  Truncus disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carlos Ibares</last_name>
    <role>Study Director</role>
    <affiliation>Cardiva2 S.L.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Universitario de Santiago de Compostela</name>
      <address>
        <city>Santiago de Compostela</city>
        <state>A Coruña</state>
        <zip>15706</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital de León</name>
      <address>
        <city>Leon</city>
        <state>León</state>
        <zip>24001</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Virgen de la Arrixaca</name>
      <address>
        <city>El Palmar</city>
        <state>Murcia</state>
        <zip>30120</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Infanta Cristina</name>
      <address>
        <city>Badajoz</city>
        <zip>06006</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Valle de Hebrón</name>
      <address>
        <city>Barcelona</city>
        <zip>08035</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Virgen de las Nieves</name>
      <address>
        <city>Granada</city>
        <zip>18014</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Juan Ramón Jiménez</name>
      <address>
        <city>Huelva</city>
        <zip>21005</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital La Paz</name>
      <address>
        <city>Madrid</city>
        <zip>28046</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Marqués de Valdecilla</name>
      <address>
        <city>Santander</city>
        <zip>39008</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Virgen de la Salud</name>
      <address>
        <city>Toledo</city>
        <zip>45005</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico Universitario de Valladolid</name>
      <address>
        <city>Valladolid</city>
        <zip>47003</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 6, 2017</study_first_submitted>
  <study_first_submitted_qc>February 9, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">February 10, 2017</study_first_posted>
  <last_update_submitted>July 18, 2017</last_update_submitted>
  <last_update_submitted_qc>July 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 19, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

